特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
763071

ボツリヌス毒素市場(製品タイプ別:ボツリヌス毒素タイプA、ボツリヌス毒素タイプB、用途別:美容、治療) - 世界の業界分析、規模、シェア、成長、動向、予測(2018~2026年)

Botulinum Toxin Market (Product Type - Botulinum Toxin Type A and Botulinum Toxin Type B; Application - Aesthetic, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026

出版日: | 発行: Transparency Market Research | ページ情報: 英文 172 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.14円
ボツリヌス毒素市場(製品タイプ別:ボツリヌス毒素タイプA、ボツリヌス毒素タイプB、用途別:美容、治療) - 世界の業界分析、規模、シェア、成長、動向、予測(2018~2026年)
出版日: 2018年11月21日
発行: Transparency Market Research
ページ情報: 英文 172 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のボツリヌス毒素市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
  • 市場分析と予測
    • 収益予測

第5章 主な考察

  • 価格比較分析
  • パイプライン分析
  • 上市と特許失効
  • 主な動向

第6章 製品タイプ別市場分析と予測

  • イントロダクション・定義
  • 主な調査結果/動向
  • 市場価値予測
    • タイプA
    • タイプB
  • 市場の魅力度

第7章 用途別市場分析と予測

  • イントロダクション・定義
  • 主な調査結果/動向
  • 市場価値予測
    • 美容
    • 治療
  • 市場の魅力度

第8章 地域別市場分析

  • 主な調査結果
  • 市場価値予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度

第9章 米国市場

第10章 欧州市場

第11章 アジア太平洋地域

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競合環境

  • 競合マトリクス
  • 市場シェア分析
  • 企業プロファイル
図表

List of Tables

  • Table 01: Global Botulinum Toxin Market: Pipeline Analysis
  • Table 02: Global Botulinum Toxin Market: Price Comparison Analysis
  • Table 03: Global Botulinum Toxin Market: Launch Snapshot
  • Table 04: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 05: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 06: Global Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 07: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 08: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 09: North America Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 10: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 11: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 12: Europe Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 13: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 14: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 15: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 16: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 17: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 18: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 19: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Product Type, 2016-2026
  • Table 20: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 21: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 22: Pipeline Products - Allergan plc
  • Table 23: Pipeline Products - Ipsen Pharma
  • Table 24: Pipeline Products - Medytox Inc.
  • Table 25: Pipeline Products - US Worldmed, LLC
  • Table 26: Pipeline Products - Revance Therapeutics, Inc.

List of Figures

  • Figure 01: Global Botulinum Toxin Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
  • Figure 02: Market Snapshot
  • Figure 03: Global Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
  • Figure 04: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016-2026
  • Figure 05: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016-2026
  • Figure 06: Global Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 07: Global Botulinum Toxin Market Value Share, by Application, 2018 and 2026
  • Figure 08: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016-2026
  • Figure 09: Global Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016-2026
  • Figure 10: Global Botulinum Toxin Market Attractiveness, by Application, 2018-2026
  • Figure 11: Global Botulinum Toxin Market Value Share, by Region, 2018 and 2026
  • Figure 12: Global Botulinum Toxin Market Attractiveness, by Region, 2018-2026
  • Figure 13: North America Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
  • Figure 14: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016-2026
  • Figure 15: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016-2026
  • Figure 16: North America Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 17: North America Botulinum Toxin Market Value Share, by Application, 2018 and 2026
  • Figure 18: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016-2026
  • Figure 19: North America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016-2026
  • Figure 20: North America Botulinum Toxin Market Attractiveness, by Application, 2018-2026
  • Figure 21: North America Botulinum Toxin Market Value Share, by Region, 2018 and 2026
  • Figure 22: North America Botulinum Toxin Market Attractiveness, by Region, 2018-2026
  • Figure 23: Europe Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
  • Figure 24: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016-2026
  • Figure 25: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016-2026
  • Figure 26: Europe Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 27: Europe Botulinum Toxin Market Value Share, by Application, 2018 and 2026
  • Figure 28: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016-2026
  • Figure 29: Europe Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016-2026
  • Figure 30: Europe Botulinum Toxin Market Attractiveness, by Application, 2018-2026
  • Figure 31: Europe Botulinum Toxin Market Value Share, by Region, 2018 and 2026
  • Figure 32: Europe Botulinum Toxin Market Attractiveness, by Region, 2018-2026
  • Figure 33: Asia Pacific Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
  • Figure 34: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016-2026
  • Figure 35: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016-2026
  • Figure 36: Asia Pacific Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 37: Asia Pacific Botulinum Toxin Market Value Share, by Application, 2018 and 2026
  • Figure 38: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016-2026
  • Figure 39: Asia Pacific Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016-2026
  • Figure 40: Asia Pacific Botulinum Toxin Market Attractiveness, by Application, 2018-2026
  • Figure 41: Asia Pacific Botulinum Toxin Market Value Share, by Region, 2018 and 2026
  • Figure 42: Asia Pacific Botulinum Toxin Market Attractiveness, by Region, 2018-2026
  • Figure 43: Latin America Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
  • Figure 44: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016-2026
  • Figure 45: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016-2026
  • Figure 46: Latin America Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 47: Latin America Botulinum Toxin Market Value Share, by Application, 2018 and 2026
  • Figure 48: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016-2026
  • Figure 49: Latin America Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016-2026
  • Figure 50: Latin America Botulinum Toxin Market Attractiveness, by Application, 2018-2026
  • Figure 51: Latin America Botulinum Toxin Market Value Share, by Region, 2018 and 2026
  • Figure 52: Latin America Botulinum Toxin Market Attractiveness, by Region, 2018-2026
  • Figure 53: Middle East & Africa Botulinum Toxin Market Value Share, Product Type, 2018 and 2026
  • Figure 54: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type A, 2016-2026
  • Figure 55: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Botulinum Toxin Type B, 2016-2026
  • Figure 56: Middle East & Africa Botulinum Toxin Market Attractiveness Analysis, by Product Type, 2018-2026
  • Figure 57: Middle East & Africa Botulinum Toxin Market Value Share, by Application, 2018 and 2026
  • Figure 58: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Aesthetic, 2016-2026
  • Figure 59: Middle East & Africa Botulinum Toxin Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Therapeutics, 2016-2026
  • Figure 60: Middle East & Africa Botulinum Toxin Market Attractiveness, by Application, 2018-2026
  • Figure 61: Middle East & Africa Botulinum Toxin Market Value Share, by Region, 2018 and 2026
  • Figure 62: Middle East & Africa Botulinum Toxin Market Attractiveness, by Region, 2018-2026
  • Figure 63: Total Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 64: Research & Development Expense (US$ Mn) and Y-o-Y Growth (%), 2014-2016
  • Figure 65: Breakdown of Net Sales (%), by Region, 2017
  • Figure 66: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 67: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 68: Dysport Sales (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 69: Breakdown of Net Sales (%), by Region, 2017
  • Figure 70: Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 71: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 72: R&D Expenses (US$ Mn), 2014-2017
  • Figure 73: Gross Profit (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 74: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 75: Revenue (US$ Mn), by Region, 2017
  • Figure 76: Revenue (US$ Mn), by Segment, 2017
  • Figure 77: Breakdown of Net Sales (%), by Region, 2017
  • Figure 78: Breakdown of Net Sales (%), by Business Segment, 2017
  • Figure 79: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 80: R&D Expenses (US$ Mn), 2014-2017
  • Figure 81: Gross Profit (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 82: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014-2017
  • Figure 83: R&D Expenses (US$ Mn), 2014-2017
目次

Global Botulinum Toxin Market: Overview

This report analyzes the current and future scenario of the global botulinum toxin market. Botulinum toxin is a neurotoxin that is produced by the bacterium clostridium botulinum. There are around eight types of botulinum toxins A-H, produced by the bacterium. Botulinum toxin type A is capable of causing diseases in humans; however, it is widely utilized commercially and medically for the treatment of several aesthetic diseases such as glabellar lines, crow's foot, and face and forehead wrinkles. Botulinum toxin is also utilized in the therapeutic treatment of spasticity, cervical dystonia, and migraine. Botulinum toxin procedure is a non-surgical cosmetic procedure that is noninvasive or minimally invasive in nature. Botulinum toxin procedure is a non-surgical and noninvasive or minimally invasive and has several advantages, such as no downtime, less time of surgery, no need of hospitalization, and faster recovery, over conventional cosmetic or aesthetic surgeries.

The global botulinum toxin market is expanding at a high pace owing to the increase in prevalence of cervical dystonia and upper limb and lower limb spasticity. Rise in global geriatric population and adoption of new non-surgical aesthetic procedures is fuelling the market. Growing incidences of glabellar lines, face and forehead wrinkles, and crow's foot and consistent worldwide rise in cases of migraine are boosting the market. Furthermore, rising number of skilled professionals performing non-surgical botulinum toxin procedures, favorable government regulations regarding the commercial usage of botulinum toxins, and advantages of faster onset of action of botulinum toxin procedure over traditional cosmetic procedure are propelling the botulinum toxin market.

This report on the global botulinum toxin market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on product type, application, and region. A detailed qualitative analysis of drivers, restraints, opportunities and trends of the market has been provided in the overview section. Additionally, the market outlook section offer key insights of the global market such as price comparison analysis, pipeline analysis and launch & patent expiry snapshot. It also provides market attractiveness analysis, in terms of region and key strategies adopted by players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global botulinum toxin market.

Global Botulinum Toxin Market: Key Segments

Botulinum toxin market has segmented into product type, application, and region. Based on product type, the botulinum toxin market has been classified into botulinum toxin type A and botulinum toxin type B. Based on application, the market has been bifurcated into aesthetic and therapeutics, which are the main application areas of the market. Each of the segments has been analyzed in detail in terms of market trends, recent developments, drivers, restraints, opportunities, and useful insights. The report gives current and future market size for each segment and sub-segment of the market for the period of 2018 to 2026, in terms of revenue depicted in US$ Mn, considering 2017 as the base year and 2016 as the historical year. The compound annual growth rate (CAGR) has been provided for each segment and the overall market for the period of 2018 to 2026, along with market size estimations.

Global Botulinum Toxin Market: Regional Outlook

In terms of region, the global botulinum toxin market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further sub-segmented into major countries and sub-regions. The current and future market size, in terms of value, of the botulinum toxin market at the regional and country level has been provided in the report for the period of 2016 to 2026, along with their growth rate in percentage for the period of 2018 to 2026. The study also provides useful insights of the market, expected to help new companies willing to enter the market and existing companies seeking to increase their market share.

Companies Mentioned in the Report

The report profiles major companies operating in the global botulinum toxin market in terms of attributes, such as, company overview, financial overview, product portfolio, business strategies, recent developments, and SWOT (strength, weakness, opportunity, and threat) analysis. Major companies mentioned are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics, Inc.

The global botulinum toxin market has been segmented as follows:

Global Botulinum toxin Market, by Product Type

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

Global Botulinum toxin Market, by Application

  • Aesthetic
  • Therapeutics

Global Botulinum toxin Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Botulinum Toxin Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. by Product Type Definition
    • 4.1.2. Market Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Increasing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures
      • 4.3.1.2. Increase in prevalence of spasticity and cervical dystonia
      • 4.3.1.3. Increasing number of products approval and new product launch in different region
      • 4.3.1.4. Rising awareness regarding botulinum toxin procedures in the geriatric population worldwide
    • 4.3.2. Restraints
      • 4.3.2.1. Short time results and repetitive nature of aesthetic and therapeutic procedures
      • 4.3.2.2. High cost of procedures and unavailability of reimbursement policies
    • 4.3.3. Opportunities
      • 4.3.3.1. Use of botulinum toxin products for the treatment of migraine and over sweating
      • 4.3.3.2. Numerous products in phase III and above clinical trials for various disease conditions
  • 4.4. Global Botulinum Toxin Market Analysis and Forecast, 2016-2026
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Price Comparison Analysis (2017)
  • 5.2. Pipeline Analysis
  • 5.3. Launch and Patent Expiry - Snapshot
  • 5.4. Key Trends
    • 5.4.1. Increasing use of botulinum toxin aesthetic treatments by men
    • 5.4.2. New and improved approaches regarding formulation types and delivery of botulinum toxin products

6. Global Botulinum Toxin Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
    • 6.3.1. Botulinum Toxin Type A
    • 6.3.2. Botulinum Toxin Type B
  • 6.4. Market Attractiveness by Product Type

7. Global Botulinum Toxin Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Botulinum Toxin Market Value Forecast, by Application, 2016-2026
    • 7.3.1. Aesthetic
    • 7.3.2. Therapeutics
  • 7.4. Global Botulinum Toxin Market Attractiveness, by Application

8. Global Botulinum Toxin Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Global Botulinum Toxin Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Global Botulinum Toxin Market Attractiveness, by Region

9. North America Botulinum Toxin Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. North America Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
    • 9.2.1. Botulinum Toxin Type A
    • 9.2.2. Botulinum Toxin Type B
  • 9.3. North America Botulinum Toxin Market Value Forecast, by Application, 2016-2026
    • 9.3.1. Aesthetic
    • 9.3.2. Therapeutics
  • 9.4. North America Botulinum Toxin Market Value Forecast, by Country, 2016-2026
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. North America Botulinum Toxin Market Attractiveness Analysis
    • 9.5.1. By Product Type
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Botulinum Toxin Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Europe Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
    • 10.2.1. Botulinum Toxin Type A
    • 10.2.2. Botulinum Toxin Type B
  • 10.3. Europe Botulinum Toxin Market Value Forecast, by Application, 2016-2026
    • 10.3.1. Aesthetic
    • 10.3.2. Therapeutics
  • 10.4. Europe Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016-2026
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Europe Botulinum Toxin Market Attractiveness Analysis
    • 10.5.1. By Product Type
    • 10.5.2. By Application
    • 10.5.3. By Country/Region

11. Asia Pacific Botulinum Toxin Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Asia Pacific Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
    • 11.2.1. Botulinum Toxin Type A
    • 11.2.2. Botulinum Toxin Type B
  • 11.3. Asia Pacific Botulinum Toxin Market Value Forecast, by Application, 2016-2026
    • 11.3.1. Aesthetic
    • 11.3.2. Therapeutics
  • 11.4. Asia Pacific Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016-2026
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Rest of Asia Pacific
  • 11.5. Asia Pacific Botulinum Toxin Market Attractiveness Analysis
    • 11.5.1. By Product Type
    • 11.5.2. By Application
    • 11.5.3. By Country/Region

12. Latin America Botulinum Toxin Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Latin America Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
    • 12.2.1. Botulinum Toxin Type A
    • 12.2.2. Botulinum Toxin Type B
  • 12.3. Latin America Botulinum Toxin Market Value Forecast, by Application, 2016-2026
    • 12.3.1. Aesthetic
    • 12.3.2. Therapeutics
  • 12.4. Latin America Botulinum Toxin Market Value Forecast, by Country/Sub-region, 2016-2026
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Latin America Botulinum Toxin Market Attractiveness Analysis
    • 12.5.1. By Product Type
    • 12.5.2. By Application
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Botulinum Toxin Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Middle East & Africa Botulinum Toxin Market Value Forecast, by Product Type, 2016-2026
    • 13.2.1. Botulinum Toxin Type A
    • 13.2.2. Botulinum Toxin Type B
  • 13.3. Middle East & Africa Botulinum Toxin Market Value Forecast, by Application, 2016-2026
    • 13.3.1. Aesthetic
    • 13.3.2. Therapeutics
  • 13.4. Middle East & Africa Botulinum Toxin Market Value Forecast, by Country/Region, 2016-2026
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Middle East & Africa Botulinum Toxin Market Attractiveness Analysis
    • 13.5.1. By Product Type
    • 13.5.2. By Application
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 14.2. Market Share Analysis by Company (2017)
  • 14.3. Company Profiles
    • 14.3.1. Allergan, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Financial Overview
      • 14.3.1.3. Product Portfolio
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. Ipsen Group
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Financial Overview
      • 14.3.2.3. Product Portfolio
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Medytox, Inc.
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Financial Overview
      • 14.3.3.3. Product Portfolio
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Merz Pharma GmbH & Co. KGaA
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Financial Overview
      • 14.3.4.3. Product Portfolio
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. US Worldmed, LLC
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
    • 14.3.6. Nestle Skin Health (Galderma)
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Financial Overview
      • 14.3.6.3. Product Portfolio
      • 14.3.6.4. SWOT Analysis
      • 14.3.6.5. Strategic Overview
    • 14.3.7. Metabiologics, Inc. (US)
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.3. Product Portfolio
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. Hugel Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Financial Overview
      • 14.3.8.3. Product Portfolio
      • 14.3.8.4. SWOT Analysis
      • 14.3.8.5. Strategic Overview
    • 14.3.9. Lanzhou Institute of Biological Products Co. Ltd.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. Revance Therapeutics, Inc.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Financial Overview
      • 14.3.10.3. Product Portfolio
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.